Results 11 to 20 of about 578 (168)
Updosing of nonsedating anti-histamines in recalcitrant chronic urticaria
Indian Journal of Dermatology, 2016 Chronic urticaria (CU) is a persistent, debiliating condition that causes severe impairment on the quality of life (QoL) of patient by interrupting work productivity.
Kiran Godse +4 more
doaj +3 more sources
Oral immunotherapy and anti-IgE antibody treatment for food allergy [PDF]
World Allergy Organization Journal, 2015 Food allergy is a major public health problem affecting nearly 10 % of children in most industrialized countries. Unfortunately, there are no effective therapies for food allergy, relegating patients to simply avoid the offending foods and treat ...
Rachid, Rima +5 more
core +3 more sources
Clinical Dermatology Review, 2022 Background: Second-generation antihistamines (SGAHs) are first-line drugs in management of chronic spontaneous urticaria (CSU). However, almost 50% of the patients do not respond to standard dose of SGAH.
Bela Shah +6 more
doaj +2 more sources
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
Therapeutics and Clinical Risk Management, 2016 Maria T Staevska Clinical Center of Allergology, Medical University, Sofia, Bulgaria As a group of allergists who treat both allergic rhinitis and urticaria patients on a daily basis, and involved in clinical research, we read with particular ...
Staevska MT
doaj +6 more sources
Antihistamines for the treatment of urticaria in Mexico
Revista Alergia México, 2015 There are four types of histamine receptors. Allergic symptoms, especially those in rhinoconjunctivitis and urticaria, are mainly caused by activation of histamine receptor 1 (H1).
Désirée Larenas-Linnemann +14 more
core +2 more sources
Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy. [PDF]
J Allergy Clin Immunol Glob, 2023 Background: Oral immunotherapy containing peanut (Arachis hypogaea) allergen powder-dnfp (PTAH) (Palforzia [Aimmune Therapeutics, Brisbane, Calif]) for 9 to 12 months resulted in higher tolerated amounts of peanut protein in PTAH-treated individuals aged
Bird JA +6 more
europepmc +3 more sources
Respiratory Medicine Case Reports, 2022 Status asthmaticus is a life-threatening condition with a high mortality rate of up to 10.3% [1].Milger et al. recently described a rapid clinical improvement and a reduction in serum IgE levels in a patient with status asthmaticus who received salvage ...
Hortense Slevogt, Martin Brauer
doaj +3 more sources
Indian Journal of Dermatology, 2018 Aim: To study the effects of omalizumab in chronic spontaneous urticaria in Indian patients. Setting and Design: The study was conducted in a tertiary care centre and it was retrospective and descriptive in nature.
Shekhar Neema, Manas Chatterjee
core +2 more sources
Turkish dermatologists' approach for chronic spontaneous urticaria: A questionnaire based study [PDF]
Dermatologica Sinica, 2017 Background/Objectives: Chronic spontaneous urticaria (CSU) is a common skin disorder which represents a challenge both for the patients and physicians. Guidelines and treatment algorithms have been created to help physicians to ease management.
Aktan Sebnem +20 more
core +3 more sources
Journal of Cutaneous Immunology and Allergy, 2019 Objectives The effect of rupatadine, a novel H1 antihistamine with platelet‐activating factor antagonist activity, had been demonstrated for itching in Japanese patients with chronic spontaneous urticaria, dermatitis, or pruritus in a 12‐month, open ...
Michihiro Hide +3 more
core +2 more sources